$IMDX
Insight Molecular Diagnostics Inc. Common Stock
XNAS•Health Care•In Vitro & in Vivo Diagnostic Substances
Why is IMDX down today? It is at $4.13 (-3.73%), and our scanner flagged it 13 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment IMDX spikes, and full due diligence on IMDX — key stats, earnings, dilution and insider activity. Free.
Get free $IMDX alerts the moment volume spikes
Our scanner flagged $IMDX 13 times in the last 30 days. Create a free account to track $IMDX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $4.13
- Change today
- -3.73%
- Previous close
- $4.29
- 52-week range
- $2.40 – $8.51
- Market cap
- $135M
- Institutional own.
- 58.03%
- Total held
- 60.2%
- Tradeable float
- 13.0M 40% of shares · after 2% insiders + 58% institutions
- Short interest
- 1.1M ▲ +1% vs prior · as of 2026-08-14
- Short % of float
- 8.4%
- Days to cover
- 3.5d
- Avg daily volume
- 172K
- Sector
- Health Care
- Industry
- In Vitro & in Vivo Diagnostic Substances
- Exchange
- XNAS
- 5m
- 0.3x
- 15m
- 0.2x
- 1h
- 0.3x
- 1D
- --
Get free IMDX + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $IMDX down today?
Here is the latest on IMDX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for IMDX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystInsight Molecular Diagnostics Inc.: Q2 FY2026 results, three months to Jun 30, 2026, from the latest SEC filing. Read it →Analyst data via Nasdaq. Not investment advice.
Insiders
Insiders buying6 open-market buys3 buys, 3 sells last 3 months (10/6 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Arno Andrew Director | Sold (automatic/other) | -12K 0.04% of company | sold 7.2% | 157K | $69K at $5.69 | Jul 1, 26 |
Last Andrew J. Director | Sold (automatic/other) | -8K 0.02% of company | sold 12% | 59K | $44K at $5.69 | Jul 1, 26 |
Silverman Lou Director | Sold (automatic/other) | -8K 0.02% of company | sold 12% | 56K | $44K at $5.69 | Jul 1, 26 |
Last Andrew J. Director | Acquired (grant/award) | +27K 0.08% of company | added 68% | 66K | n/a | Jun 11, 26 |
Arno Andrew Director | Acquired (grant/award) | +32K 0.10% of company | added 24% | 169K | n/a | Jun 11, 26 |
Silverman Lou Director | Acquired (grant/award) | +27K 0.08% of company | added 74% | 64K | n/a | Jun 11, 26 |
Broadwood Partners, L.P. Beneficial Owner (10%) | Bought (open market) | +251K 0.8% of company | added 2.0% | 12.68M | $913K at $3.64 | Apr 27, 26 |
Broadwood Partners, L.P. Beneficial Owner (10%) | Bought (open market) | +39K 0.1% of company | added 0.3% | 12.43M | $137K at $3.53 | Apr 24, 26 |
Broadwood Partners, L.P. Beneficial Owner (10%) | Bought (open market) | +280K 0.9% of company | added 2.3% | 12.40M | $981K at $3.50 | Apr 23, 26 |
Broadwood Partners, L.P. Beneficial Owner (10%) | Bought (open market) | +41K 0.1% of company | added 0.3% | 12.11M | $158K at $3.88 | Apr 20, 26 |
Broadwood Partners, L.P. Beneficial Owner (10%) | Bought (open market) | +40K 0.1% of company | added 0.3% | 12.07M | $143K at $3.57 | Apr 17, 26 |
Broadwood Partners, L.P. Beneficial Owner (10%) | Bought (open market) | +102K 0.3% of company | added 0.9% | 12.03M | $352K at $3.45 | Apr 16, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Recent offeringRecent priced share offering — a one-time sale that has already completed (not ongoing). If $IMDX runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
- 4,525,976 new shares
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$IMDX Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$IMDX Activity
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Stocks similar to IMDX
Comparable names in in vitro & in vivo diagnostic substances, closest in size first.
IMDX stock FAQ
Why is $IMDX down today?
Here is the latest on IMDX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for IMDX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
What is the IMDX stock price today?
IMDX last traded at $4.13, down 3.73% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live IMDX alerts?
The IMDX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged IMDX 13 times in the last 30 days.
What exchange is IMDX on?
IMDX (Insight Molecular Diagnostics Inc. Common Stock) trades on XNAS, with a market cap of about $135M in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector.
Is IMDX good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge IMDX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.